• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

MHE Talks: Wes Gilson of Siemens Healthineers Addresses How Crucial Improving Access to MRI is to Advancing Health Equity

Article

Welcome back to another episode of the returned MHE Talks: Improving Patient Access podcast. In this episode Briana Contreras, editor of Managed Healthcare Executive, spoke with Wes Gilson, senior director MR of Business Development at Siemens Healthineers. In the conversation, the two discussed why improving access to magnetic resonance imaging (MRI) is crucial to advancing health equity. Gilson addressed the barriers many face when accessing MRI services and its solutions from tackling the barriers specific to areas affected, alternative technologies, developing new innovations in MRI tech and more.

Gilson

Gilson

Related Content
© 2024 MJH Life Sciences

All rights reserved.